Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Historical Holders from Q2 2019 to Q3 2025

Symbol: ARCT on Nasdaq
Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 27,163,993
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 25,813,853
Holdings value: $475,545,761
% of all portfolios: 0%
Number of holders: 134
Number of buys: 69
Number of sells: -67
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BALYASNY ASSET MANAGEMENT L.P.	8.04%		$40,250,844		2,183,985		Balyasny Asset Management L.P.	30 Sep 2025
BlackRock, Inc.	7.8%		$27,169,573		2,104,537		BlackRock, Inc.	31 Mar 2025
Sumitomo Mitsui Trust Group, Inc.	7.2%	+1.4%	$35,898,599	+$400,871	1,947,835	+1.1%	Sumitomo Mitsui Trust Group, Inc.	30 Sep 2025
Amova Asset Management Americas, Inc.	7.2%	+1.4%	$35,898,599	+$400,871	1,947,835	+1.1%	Amova Asset Management Americas, Inc.	30 Sep 2025
VANGUARD GROUP INC	6.67%		$23,550,428		1,810,165		The Vanguard Group	30 Jun 2025
ARK Investment Management LLC	6.32%		$22,312,842		1,715,040		ARK Investment Management LLC	30 Jun 2025
STATE STREET CORP	4.9%		$17,120,700		1,326,158		STATE STREET CORPORATION	31 Dec 2024

Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	25,813,853	$475,545,761	+$6,867,356	$15,957,208	$40,656,967	$18.43	134
2025 Q2	25,723,468	$335,038,354	-$6,831,289	$1,775,110	$4,176,210	$13.01	140
2025 Q1	26,575,062	$281,454,102	-$6,198,440	$1,032,231	$3,303,021	$10.59	141
2024 Q4	26,610,345	$451,455,958	+$561,441	$2,925,220	$2,757,625	$16.97	144
2024 Q3	26,254,849	$609,261,942	-$9,219,231	$3,074,875	$4,503,315	$23.21	163
2024 Q2	26,274,363	$639,738,709	-$34,874,203	$3,732,855	$7,782,760	$24.35	169
2024 Q1	27,205,455	$918,443,053	+$63,004,519	$10,745,614	$9,918,249	$33.77	176
2023 Q4	25,425,877	$801,644,603	+$9,906,113	$7,567,200	$6,870,387	$31.53	165
2023 Q3	25,171,045	$643,113,548	+$38,194,974	$5,260,745	$5,204,535	$25.55	146
2023 Q2	23,633,969	$677,565,419	+$11,461,734	$6,982,992	$4,063,956	$28.68	143
2023 Q1	23,320,944	$557,885,187	+$17,248,370	$4,170,780	$4,058,121	$23.97	124
2022 Q4	22,638,074	$383,920,663	+$11,521,684	$2,226,848	$4,928,576	$16.96	111
2022 Q3	22,166,410	$328,065,176	-$1,828,982	$2,202,000	$4,139,000	$14.82	106
2022 Q2	20,644,930	$334,480,556	+$9,251,825	$4,280,000	$9,331,000	$15.74	116
2022 Q1	21,454,944	$578,272,039	+$36,976,142	$5,988,000	$13,766,000	$26.96	122
2021 Q4	19,955,158	$736,203,155	+$29,436,784	$7,672,000	$24,973,000	$37.01	133
2021 Q3	19,065,552	$909,015,330	-$50,289,411	$11,047,000	$20,637,000	$47.78	150
2021 Q2	20,506,601	$693,959,237	+$36,673,317	$7,445,000	$5,661,000	$33.84	133
2021 Q1	18,787,112	$775,920,001	-$48,861,238	$21,344,000	$29,296,000	$41.3	153
2020 Q4	19,874,000	$864,074,837	+$70,349,611	$31,329,660	$37,401,840	$43.38	131
2020 Q3	18,215,804	$783,103,294	+$221,938,988	$13,697,000	$22,797,000	$42.9	127
2020 Q2	12,949,979	$605,805,587	+$388,736,954	$17,805,000	$13,233,000	$46.74	112
2020 Q1	4,735,510	$65,692,000	+$2,316,123	$1,288,000	$917,000	$13.59	53
2019 Q4	4,554,811	$50,089,000	-$172,871	$434,000	$365,000	$10.87	49
2019 Q3	4,612,453	$47,342,000	+$27,908,866	$335,000	$316,000	$10.27	39
2019 Q2	1,877,652	$17,728,000	+$17,719,999	$129,000	$376,000	$9.44	20